Masaru Komiyama

Shizuoka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Effect of STAT3 inhibition on the metabolic switch in a highly STAT3-activated lymphoma cell line.

Effect of STAT3 inhibition on the metabolic switch in a highly STAT3-activated lymphoma cell line.

Journal: Cancer genomics & proteomics

Published: May 16, 2015

Immunologically augmented skin flap as a novel dendritic cell vaccine against head and neck cancer in a rat model.

Immunologically augmented skin flap as a novel dendritic cell vaccine against head and neck cancer in a rat model.

Journal: Cancer science

Published: October 18, 2014

The identification of affinity peptide ligands specific to the variable region of human antibodies.

The identification of affinity peptide ligands specific to the variable region of human antibodies.

Journal: Biomedical research (Tokyo, Japan)

Published: April 25, 2014

YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line.

YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line.

Journal: Oncology reports

Published: March 06, 2014

Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line.

Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line.

Journal: International journal of oncology

Published: February 17, 2014

Anti-vascular endothelial growth factor receptor (VEGFR) 2 autoantibody identification in glioblastoma patient using single B cell-based antibody gene cloning.

Anti-vascular endothelial growth factor receptor (VEGFR) 2 autoantibody identification in glioblastoma patient using single B cell-based antibody gene cloning.

Journal: Immunology letters

Published: December 17, 2013

Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients.

Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients.

Journal: Oncology reports

Published: December 10, 2013

Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.

Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.

Journal: International journal of oncology

Published: January 15, 2013

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial.

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial.

Journal: BMC cancer

Published: August 22, 2012

Identification of novel MAGE-A6- and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay.

Identification of novel MAGE-A6- and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay.

Journal: Cancer immunology, immunotherapy : CII

Published: October 27, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026